Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Intervalo de año de publicación
1.
Biomed Res Int ; 2017: 8248094, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28630870

RESUMEN

OBJECTIVE: Abnormal expression of ABCA1 and ABCG1 in the placenta can elicit lipid metabolism disorder and adverse pregnancy outcomes. However, whether it is associated with preterm delivery remains unclear. Our present study aimed to evaluate the relationship between abnormal expression of ABCA1 or ABCG1 and preterm delivery. METHODS: Maternal blood and placental tissues from women with spontaneous deliveries (SPD), iatrogenic deliveries (IPD), and term deliveries (TD) were collected. The lipid content and expression of ABCA1 and ABCG1 were subsequently measured. RESULTS: Compared with IPD and TD groups, the HDL, TD, LDL, and TC levels were lower in the maternal blood but higher (except TC) in the cord blood of the SPD group. The extracellular lipid content in the placentas of the SPD group was also notably lower relative to the IPD and TD groups. Moreover, the protein and mRNA expressions of ABCA1 in the placentas of the SPD group were significantly higher compared with the IPD and TD groups; however, there was no obvious difference among the three groups in the protein and mRNA expressions of ABCG1. CONCLUSIONS: Abnormal expression of ABCA1 may be associated with the dysregulation of placental lipid metabolism and the occurrence or development of SPD.


Asunto(s)
Transportador 1 de Casete de Unión a ATP/biosíntesis , Regulación de la Expresión Génica , Trabajo de Parto Prematuro/metabolismo , Placenta/metabolismo , Proteínas Gestacionales/biosíntesis , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 1/biosíntesis , Adulto , Femenino , Humanos , Enfermedad Iatrogénica , Metabolismo de los Lípidos , Lípidos/sangre , Trabajo de Parto Prematuro/patología , Placenta/patología , Embarazo
3.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-329801

RESUMEN

<p><b>OBJECTIVE</b>To investigate the role of TXNDC5 in serum starvation-induced proliferation inhibition of HeLa cell.</p><p><b>METHODS</b>TXNDC5 was either over-expressed or knocked down by small interfering RNA (siRNA) in HeLa cells which were then cultured in conventional medium or serum starvation medium. The protein level of TXNDC5 was evaluated by Western blot analysis. The mRNA level of TXNDC5 was measured by quantitative real-time PCR. Cell growth rate was determined by cell proliferation assay kit (MTS method). Cell cycle distribution and apoptosis were detected by flow cytometry.</p><p><b>RESULTS</b>Serum starvation mildly reduced the mRNA level of TXNDC5 (P<0.05), but dramatically increased the protein level of TXNDC5 in HeLa cells. The stability of TXNDC5 mRNA remained unchanged. Cycloheximide abolished the serum starvation-induced up-regulation of TXNDC5 protein. Over-expression of TXNDC5 had no effect on cell proliferation. However, suppression of TXNDC5 attenuated the proliferation inhibition of HeLa cell induced by serum starvation (P<0.05), increased the proportion of cells in S phase (P<0.05), but had no effect on cell apoptosis.</p><p><b>CONCLUSION</b>TXNDC5 mediates serum starvation-induced proliferation inhibition of HeLa cell.</p>


Asunto(s)
Humanos , Apoptosis , Ciclo Celular , Proliferación Celular , Medios de Cultivo , Química , Técnicas de Silenciamiento del Gen , Células HeLa , Proteína Disulfuro Isomerasas , Genética , Metabolismo , Suero , Química
4.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-1033172

RESUMEN

Objective To investigate the effect of BDNF on cell injuries, cell apoptosis especially, induced by 25-35 segment of β-amyloid protein (Aβ25-35) at condensed state in PC12 cells.Methods The viability of PC12 cells, the apoptosis of PC12 cells and the expressions of Bax and Bcl-2 were detected by MTT, Annexin V-PI staining and Western blotting, respectively. Trk B receptor inhibitor K252a (200 nmol/l) was employed to observe the mechanism of 50 ng/ml BDNF on Aβ25-35 (20 μmol/L)-induced cell injury. Results BDNF (50 ng/ml) could significantly prevent the decrease of cell viability and cell apoptosis, and the increase of Bax expression and the decrease of Bcl-2 expression induced by 20 μmol/L Aβ25-35, and prevent the increase of up-regulation of Bax/Bcl-2 ratio; and these effects were blocked by K252a (200 nmol/1). Conclusion BDNF can prevent Aβ25-35-induced cell injury, cell apoptosis especially, by binding to its specific receptor Trk B.

5.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-299062

RESUMEN

<p><b>OBJECTIVE</b>To clone the pokeweed anti-viral protein (PAP) gene, to express it in Pichia pastoris, and to study the inhibitory effect of PAP on U251 in vitro.</p><p><b>METHODS</b>The cDNA sequence encoding PAP was cloned by Real-time PCR from Phytolacca americana. The recombinant PAP was subcloned into the expression vector pPICZaA and expressed in Pichia pastoris GSI15 after methanol induction. SDS-PAGE analysis showed that the expressed PAP existed in the yeast culture supernatant. The drug cytotoxicity to U251 cells was assessed using MTT assay and the obvious apoptotic nuclei of the tumor cells detected using the method of single cell gel electrophoresis.</p><p><b>RESULTS</b>The full-length PAP gene was cloned. The recombinant expression plasmid pPICZaA-PAP was constructed successfully. SDS-PAGE analysis showed that the relative molecular mass (M) of the recombinant protein was about 35 kDa. The degradation of the genome of the apoptotic cells induced by PAP was detected using the method of single cell gel electrophoresis. PAP possessed very high ability to inhibit the growth of U251. The anti-tumor activities (IC50) to U251 cells of PAP was 81.0 microg/mL.</p><p><b>CONCLUSION</b>PAP could be a potent anti-tumor candidate for inhibiting the growth of U251 and inducing its apoptosis.</p>


Asunto(s)
Humanos , Antineoplásicos Fitogénicos , Farmacología , Apoptosis , Línea Celular Tumoral , Pichia , Metabolismo , Proteínas Inactivadoras de Ribosomas Tipo 1 , Farmacología
6.
Chinese Medical Journal ; (24): 1864-1870, 2010.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-241796

RESUMEN

<p><b>BACKGROUND</b>Alzheimer's disease (AD) is a neurodegenerative disorder and the leading cause of dementia in the elderly. The two hallmark lesions in AD brain are deposition of amyloid plaques and neurofibrillary tangles (NFTs). Hypercholesteremia is one of the risk factors of AD. But its role in the pathogenesis of AD is largely unknown. The aim of this study was to investigate the relationship between hypercholesteremia and tau phosphorylation or beta-amyloid (Abeta), and evaluate the effect of atorvastatin on the level of tau phosphorylation and Abeta in the brains of rats fed with high cholesterol diet.</p><p><b>METHODS</b>Sprague-Dawley (SD) rats were randomly divided into normal diet control group, high cholesterol diet group, and high cholesterol diet plus atorvastatin (Lipitor, 15 mg x kg(-1) x d(-1)) treated group. Blood from caudal vein was collected to measure total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) and high-density lipoprotein (HDL) at the end of the 3rd and the 6th months by an enzymatic method. The animals were sacrificed 6 months later and brains were removed. All left brain hemispheres were fixed for immunohistochemistry. Hippocampus and cerebral cortex were separated from right hemispheres and homogenized separately. Tau phosphorylation and Abeta in the brain tissue were determined by Western blotting (using antibodies PHF-1 and Tau-1) and anti-Abeta40/anti-Abeta42, respectively.</p><p><b>RESULTS</b>We found that high cholesterol diet led to hypercholesteremia of rats as well as hyperphosphorylation of tau and increased Abeta level in the brains. Treatment of the high cholesterol diet fed rats with atorvastatin prevented the changes of both tau phosphorylation and Abeta level induced by high cholesterol diet.</p><p><b>CONCLUSIONS</b>Hypercholesteremia could induce tau hyperphosphorylation and Abeta production in rat brain. Atorvastatin could inhibit tau hyperphosphorylation and decrease Abeta generation. It may play a protective role in the patho-process of hypercholesteremia-induced neurodegeneration in the brain.</p>


Asunto(s)
Animales , Masculino , Ratas , Administración Oral , Péptidos beta-Amiloides , Metabolismo , Anticuerpos Monoclonales , Atorvastatina , Western Blotting , Encéfalo , Metabolismo , Ensayo de Inmunoadsorción Enzimática , Ácidos Heptanoicos , Farmacología , Usos Terapéuticos , Inmunohistoquímica , Fosforilación , Pirroles , Farmacología , Usos Terapéuticos , Ratas Sprague-Dawley , Proteínas tau , Metabolismo
7.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-323648

RESUMEN

<p><b>OBJECTIVE</b>To examine the effect of estrogen on the expressions of phosphorylated Tau (P-Tau), ChAT and nerve growth factor (NGF) protein in the brain tissue of rat models of Alzheimer disease (AD).</p><p><b>METHODS</b>Rat models of AD were established by injecting Aβ1-42 protein fragments in the right lateral ventricle. Two weeks later, 17β-estradiol tablets were implanted subcutaneously at the neck of the rats and maintained for 30 days. The pathological changes in the rats' brain neurons and alterations in the expressions of P-Tau, ChAT and NGF proteins were observed using HE staining and immunohistochemistry, respectively.</p><p><b>RESULTS</b>In the AD rats, neurofibrillary tangles occurred in the brain tissue, and estrogen treatment significantly reduced the formation of neurofibrillary tangles. Estrogen treatment also resulted in lowered P-Tau expression and increased ChAT and NGF protein expressions in comparison with those in the AD model rats.</p><p><b>CONCLUSION</b>Estrogen can up-regulate ChAT and NGF and down-regulate tau protein expression, thus producing obvious therapeutic effect on AD in rats.</p>


Asunto(s)
Animales , Masculino , Ratas , Enfermedad de Alzheimer , Metabolismo , Patología , Encéfalo , Metabolismo , Modelos Animales de Enfermedad , Estradiol , Farmacología , Factores de Crecimiento Nervioso , Metabolismo , Neuronas , Metabolismo , Fosforilación , Ratas Sprague-Dawley , Proteínas tau , Metabolismo
8.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-676256

RESUMEN

Objective To investigate the relationship of folates,vitamin B_(12) with tan phosphorylation and the possible mechanism in Alzhcimer's disease (AD).Method Tau protein phosphorylation was examined in hippocampns of rats of two months old and forty months old treated or untreated by folates and vitamin B_(12) using Western blot and immunohistochemistry with phosphorylation dependent and independent tau antibodies.Results We found that tau phosphorylation in aged rat brain showed a significant higher level than that in the two-month olds.Folates combined with vitamin.B_(12) could decrease tau phosphorylation by 27% at the site of Ser396/404 of hippoeampus in aged rats.Conclusion It suggests folates and vitamin B_(12) may play an important role in preventing the neurodegenerative change via effeeting tau phosphorylation in AD brain.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA